Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 12/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 10/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 10/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 9/20 | 0.35 |
| ▸ | USP2 | O75604 | 5/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 8/20 | 0.34 |
| ▸ | LMNA | P02545 | 6/20 | 0.34 |
| ▸ | CLK4 | Q9HAZ1 | 4/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | HBB | P68871 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1892112 | 0.82 | CYP1A2 (0.44) | FDPSLTA4HHDAC1HDAC6CYP1A2 | |
| SCHEMBL1398869 | 0.82 | FDPS (0.41) | FDPSLTA4HHDAC1HDAC6CYP1A2 | |
| SCHEMBL13281305 | 0.80 | FDPS (0.41) | FDPSLTA4HHDAC1HDAC6CYP1A2 | |
| Hydrochloric Acid SCHEMBL28215610 | 0.79 | LTA4H (0.38) | FDPSLTA4HHDAC1HDAC6CYP1A2 | |
| SCHEMBL9127081 | 0.77 | FDPS (0.38) | FDPSHDAC1HDAC6CYP1A2ALDH1A1 | |
| SCHEMBL1831225 | 0.76 | FDPS (0.42) | FDPSLTA4HHDAC1HDAC6CYP1A2 | |
| SCHEMBL5440115 | 0.76 | LTA4H (0.50) | FDPSLTA4HHDAC1HDAC6CYP1A2 | |
| SCHEMBL5495655 | 0.76 | FDPS (0.42) | FDPSLTA4HHDAC1HDAC6CYP1A2 | |
| SCHEMBL1436456 | 0.76 | FDPS (0.39) | FDPSLTA4HHDAC1HDAC6CYP1A2 | |
| SCHEMBL5759584 | 0.76 | FDPS (0.34) | FDPSLTA4HHDAC1HDAC6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2152878-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE (PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | Sirna Therapeutics Inc. (US) | 2010-02-17 | — | — | EP | disclosed |
| EP-2152870-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE (PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | Sirna Therapeutics Inc. (US) | 2010-02-17 | — | — | EP | disclosed |
| EP-2152875-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE (PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | Sirna Therapeutics Inc. (US) | 2010-02-17 | — | — | EP | disclosed |
| EP-2152877-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE ( PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | Sirna Therapeutics Inc. (US) | 2010-02-17 | — | — | EP | disclosed |
| EP-2152876-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE (PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | Sirna Therapeutics Inc. (US) | 2010-02-17 | — | — | EP | disclosed |
| WO-2008137761-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE (PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | SIRNA THERAPEUTICS, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008137751-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE (PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | SIRNA THERAPEUTICS, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008137771-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE ( PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008137775-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE (PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008137776-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE (PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | SIRNA THERAPEUTICS, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| EP-1987145-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS | Sirna Therapeutics Inc. (US) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007076328-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS | SIRNA THERAPEUTICS, INC. (US) | 2007-07-05 | — | — | WO | disclosed |